Candriam SCA’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-210,000
Closed -$5.54M 895
2023
Q1
$5.54M Hold
210,000
0.04% 342
2022
Q4
$6.55M Buy
+210,000
New +$6.55M 0.04% 338